Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 5Other hematologic neoplasm 4Breast 3Plasma cell 2CNS 2Thoracic 1Sarcoma 1Other neoplasm 1Myeloid 1Gynecologic 1Dermatologic 1Classical hematology 1

Conditions

Myelodysplastic Syndromes 63Anemia, Refractory, with Excess of Blasts 60Precursor Cell Lymphoblastic Leukemia-Lymphoma 58Leukemia, Myeloid, Acute 58Leukemia 50Leukemia, Lymphocytic, Chronic, B-Cell 41Multiple Myeloma 40Leukemia, Myelomonocytic, Chronic 38Lymphoma 37Lymphoma, Non-Hodgkin 36Leukemia, Myeloid, Chronic-Phase 36Myeloproliferative Disorders 34Hodgkin Disease 34Leukemia, Myeloid, Accelerated Phase 32Lymphoma, Follicular 31Anemia, Refractory 30Primary Myelofibrosis 29Burkitt Lymphoma 28Lymphoma, Mantle-Cell 27Leukemia, Myelogenous, Chronic, BCR-ABL Positive 25Lymphoma, B-Cell, Marginal Zone 24Congenital Abnormalities 24Anemia, Aplastic 23Myelodysplastic-Myeloproliferative Diseases 22Lymphoma, Large B-Cell, Diffuse 22Lymphoma, Large-Cell, Immunoblastic 21Neoplasms, Plasma Cell 20Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 20Dendritic Cell Sarcoma, Interdigitating 20Blast Crisis 20

Interventions

pegfilgrastim 2Epoetin Alfa 2Cisplatin 2sodium thiosulfate 1etoposide phosphate 1Rituximab 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Erythropoietin 1Docetaxel 1Darbepoetin alfa 1Cytarabine 1Cyclophosphamide 1Carboplatin 1Brachytherapy 12,2'-dithiodiethanesulfonic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Drug-Related Side Effects and Adverse Reactions × Cyclophosphamide × Classical hematology × Clear all
NCT00074165 2023-07-06

Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen

OHSU Knight Cancer Institute

Phase 2 Terminated
17 enrolled 7 charts
CNSClassical hematologyLymphoid

Lymphoma, Thrombocytopenia, Central Nervous System Neoplasms, Intraocular Lymphoma, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡